- ONC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
BeiGene (ONC) 8-K28 Dec 20XGEVA® (denosumab) from BeiGene’s strategic collaboration with Amgen is included in one approved indicationFinancial data
Company Profile